Lukong lab - Cell Signal paper

BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1

Vizeacoumar lab - Cell Reports paper with Freywald lab

Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR

Vizeacoumar lab - Clin Canc Res paper with Freywald lab

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy

Lukong lab - Heliyon paper

Seeking a better understanding of the non-receptor tyrosine kinase, SRMS

Vizeacoumar lab - Methods Mol Biol. paper

A CRISPR Platform for Targeted In Vivo Screens

Wu & Vizeacoumar labs - Front Oncol. paper

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy

Anderson & Vizeacoumar labs - Sci Rep paper

Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel

Congratulations Dean Chamberlain was awarded a grant from the Saskatchewan Health Research Foundation

Development of 3D tissue engineered tumour microtissue models for precision medicine

Xiang lab - Int J Mol Sci paper

The Critical Role of AMPKα1 in Regulating Autophagy and Mitochondrial Respiration in IL-15-Stimulated mTORC1Weak Signal-Induced T Cell Memory: An Interplay between Yin (AMPKα1) and...

Lukong lab - J Cancer Res Clin Oncol paper

Triple negative breast cancer: approved treatment options and their mechanisms of action

Vizeacoumar lab - Cells paper

A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers

Anderson lab - PLoS One paper

Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis